These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14746036)

  • 1. Prospects for primary prevention of cervical cancer in developing countries.
    Franceschi S; Clifford G; Plummer M
    Salud Publica Mex; 2003; 45 Suppl 3():S430-6. PubMed ID: 14746036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for HPV prevention.
    Plummer M; Franceschi S
    Virus Res; 2002 Nov; 89(2):285-93. PubMed ID: 12445668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for phase III-IV HPV vaccination trials in the Nordic countries and in Estonia.
    Lehtinen M; Kibur M; Luostarinen T; Anttila A; Pukkala E
    J Clin Virol; 2000 Oct; 19(1-2):113-22. PubMed ID: 11091154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG; ter Harmsel WA; van Doorn LJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer.
    García-Carrancá A
    Salud Publica Mex; 2003; 45 Suppl 3():S437-42. PubMed ID: 14746037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].
    Monsonego J
    Presse Med; 2007 Apr; 36(4 Pt 2):640-66. PubMed ID: 17350792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccines.
    Stanley M
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX
    Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects].
    Hantz S; Alain S; Denis F
    Presse Med; 2005 Jun; 34(10):745-53. PubMed ID: 16026130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How will HPV vaccines affect cervical cancer?
    Roden R; Wu TC
    Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control.
    Franco EL; Harper DM
    Vaccine; 2005 Mar; 23(17-18):2388-94. PubMed ID: 15755633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment.
    Bogani G; Leone Roberti Maggiore U; Signorelli M; Martinelli F; Ditto A; Sabatucci I; Mosca L; Lorusso D; Raspagliesi F
    Crit Rev Oncol Hematol; 2018 Feb; 122():92-97. PubMed ID: 29458794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development.
    Lazcano-Ponce E; Alonso P; Ruiz-Moreno JA; Hernández-Avila M
    Salud Publica Mex; 2003; 45 Suppl 3():S449-62. PubMed ID: 14746039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
    Guo T; Eisele DW; Fakhry C
    Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
    Poljak M
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
    Goldie SJ; Kohli M; Grima D; Weinstein MC; Wright TC; Bosch FX; Franco E
    J Natl Cancer Inst; 2004 Apr; 96(8):604-15. PubMed ID: 15100338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.